Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | BID | P55957 | 3/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.34 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.34 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.34 |
| ▸ | CTRC | Q99895 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | EP300 | Q09472 | 1/20 | 0.34 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.34 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29651833 | 1.00 | CYP3A4 (0.51) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL2350176 | 0.95 | CYP3A4 (0.46) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885134 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885474 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL10400982 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL13725696 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885574 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5884676 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL5885360 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 | |
| SCHEMBL29554576 | 0.93 | LIPG (0.49) | CYP3A4CYP2D6CYP2C9GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3873962-A2 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-09-08 | — | — | EP | claimed |
| EP-3681924-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | Covestro Deutschland AG (DE) | 2020-07-22 | — | — | EP | claimed |
| EP-3500611-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS | Covestro Deutschland AG (DE) | 2019-06-26 | — | — | EP | claimed |
| WO-2019052994-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-21 | — | — | WO | claimed |
| WO-2018033562-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2018-02-22 | — | — | WO | claimed |
| EP-3256508-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | Covestro Deutschland AG (DE) | 2017-12-20 | — | — | EP | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| US-20240001334-A1 | ACTIVE HYDROGEN-CONTAINING ORGANIC COMPOUND SCAVENGER, COMPOSITION, AND APPLICATIONS THEREOF | TOSOH CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
| WO-2021211123-A1 | ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIA | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2021-10-21 | — | — | WO | disclosed |
| EP-2078724-B1 | PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES | ASAHI CHEMICAL IND (JP) | 2016-11-30 | — | — | EP | disclosed |
| CN-104870517-A | FLUORENE-BASED POLYMER, FLUORENE-BASED DIOL COMPOUND AND METHOD FOR PRODUCING SAME | TAOKA CHEMICAL CO LTD | 2015-08-26 | — | — | CN | disclosed |
| CN-104812797-A | Fluorene polymer, fluorene diol compound, and method for producing said polymer and compound | TAOKA CHEMICAL CO LTD | 2015-07-29 | — | — | CN | disclosed |
| US-8008518-B2 | Process for producing dialkyl tin dialkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| CN-1549714-A | Aminoisoxazole derivatives active as kinase inhibitors | — | 2004-11-24 | — | — | CN | disclosed |
| EP-1465858-A2 | PHENY(ALKYL)CARBOXYLIC ACID DERIVATIVES AND DIONIC PHENYLALKYLHETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDICINES WITH SERUM GLUCOSE AND/OR SERUM LIPID LOWERING ACTIVITY | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2004-10-13 | — | — | EP | disclosed |
| WO-2004009549-A2 | PIPERIDINES USEFUL FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ACTELION PHARMACEUTICALS LTD (CH) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003059864-A2 | PHENY(ALKYL)CARBOXYLIC ACID DERIVATIVES AND DIONIC PHENYLALKYLHETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDICINES WITH SERUM GLUCOSE AND/OR SERUM LIPID LOWERING ACTIVITY | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2003-07-24 | — | — | WO | disclosed |
| US-4041019-A | 1-(N-SUBSTITUTED CARBAMOYL)-IMIDAZOLES | THE DOW CHEMICAL COMPANY (US) | 1977-08-09 | — | — | US | disclosed |
| US-3961061-A | INSECTICIDES, FUNGICIDES, BACTERICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
| US-3933701-A | High resilience polyurethane foam | OLIN CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240001334-A1 | ACTIVE HYDROGEN-CONTAINING ORGANIC COMPOUND SCAVENGER, COMPOSITION, AND APPLICATIONS THEREOF | CBR1, ADH1C, ADH1A | CYP3A4 774/4885CYP2D6 3565/4885CYP2C9 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.